OVA sequence 323-336

OVA sequence 323-336 is a synthetic peptide corresponding to amino acids 323 through 336 of chicken ovalbumin, a well-characterized protein frequently used as a model antigen in immunological research. This peptide segment is widely recognized for its defined sequence and immunodominant properties, making it a valuable tool in the study of antigen processing, T cell recognition, and peptide-MHC interactions. Its precise composition enables reproducible experimental outcomes, supporting both fundamental and applied studies in immunology, peptide biochemistry, and cellular signaling.

Epitope mapping: The 323-336 fragment of ovalbumin is a prototypical epitope for MHC class II-restricted T cell responses, particularly in murine models. Researchers utilize this peptide to map and characterize CD4+ T cell epitopes, enabling detailed analysis of antigen-specific immune responses. Its use facilitates the identification of T cell receptor specificity, the delineation of immunodominant regions within larger proteins, and the validation of novel immunological assays.

Antigen presentation studies: In investigations of antigen processing and presentation, the OVA 323-336 peptide serves as a defined substrate for dissecting the mechanisms of peptide loading onto MHC class II molecules. By bypassing the need for intracellular processing of whole ovalbumin protein, this peptide allows for direct assessment of MHC-peptide complex formation, trafficking, and stability on antigen-presenting cells. Such studies are critical for understanding the molecular basis of adaptive immunity and for optimizing experimental protocols in immunological research.

T cell activation assays: The well-characterized immunogenicity of this peptide makes it a standard reagent for in vitro and in vivo T cell activation experiments. It is commonly used to stimulate OVA-specific CD4+ T cells, such as those derived from transgenic mouse models (e.g., OT-II mice), enabling the quantification of T cell proliferation, cytokine secretion, and differentiation. These assays provide valuable insights into T cell biology, immune tolerance, and the functional consequences of antigen recognition.

Peptide-MHC binding analysis: OVA 323-336 is frequently employed in quantitative and qualitative studies of peptide-MHC class II binding. Its defined sequence and known affinity for specific MHC alleles allow researchers to assess the impact of sequence modifications, peptide length, or competitive inhibitors on MHC binding dynamics. Such analyses inform the design of novel immunogens, peptide vaccines, and immune modulators, as well as the development of computational prediction tools for epitope identification.

Immunological method development: Due to its reproducibility and well-established immunological profile, this peptide is often chosen as a reference standard in the development and validation of immunological techniques. Applications include the calibration of flow cytometry panels, optimization of ELISPOT and ELISA assays, and benchmarking of novel antigen delivery systems. Its consistent performance supports the generation of reliable, comparable data across experimental platforms, facilitating advances in both basic and translational immunology.

1. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

2. Cationic cell-penetrating peptides are potent furin inhibitors

3. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

4. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

5. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients